Date:
Thursday, October 16, 2014
by Steven Ertelt | LifeNews.com | 10/15/14 6:42 PM
With concerns about the Ebola virus on the minds of Americans and people worldwide given new
infections, one pro-life group is hoping that moral alternatives will be pursued when creating an Ebola
vaccine. Children of God for Life announced today that several Ebola vaccines in development for use worldwide
are made using aborted fetal cell lines despite the fact that moral alternatives are reported as equally
effective. As the pro-life group informed LifeNews.com: Glaxo SmithKline (GSK) and NIAID are jointly developing their
ChAd3 vector for delivering the Ebola virus gene using HEK-293 (human embryonic kidney) cells.
Likewise, NewLink Genetics of Iowa used HEK-293 cells for their VSV-EBOV Ebola vaccine in Canada, while Johnson and
Johnson/Crucell developed theirs using PER C6 cells, derived from retinal tissue of an 18 week
gestation aborted baby. “There is absolutely no reason to use aborted fetal cell lines,” stated Debi Vinnedge, Director of Children of
God for Life. “At least two other Ebola vaccines in development by the University of Texas and GeoVax
are using either Vero cells or chicken eggs. Likewise, there are therapeutic products such as ZMapp
(LeafBio) and TKM-Ebola (Tekmira) that are using plant or Vero cells.”
Vinnedge wrote to the Department of HHS, the NIH, the FDA and NIAID pointing out that even the US
Department of Health listed other options such as yeast, insect, plant, bacteria, CHO, BHK, heLa and COS
cells, in their own patent, stating, “The attenuated [ebola]virus can replicate well in a cell line that lacks
interferon functions, such as Vero cells.” “It is completely irresponsible of this Administration to put these problem vaccines on fast-track for approval
and ignore the fact that a massive number of people may very well refuse them. Why not fast track a
product that everyone can use in good conscience?” asked Vinnedge.
The pro-life group is urging pro-life Americans to contact the Obama administration and their members of
Congress requesting that they expedite the morally acceptable alternatives.
Contact:
Sylvia M. Burwell, Secretary
Dept of Health and Human Services
200 Independence Avenue
Washington, DC 20201
Dr Francis S. Collins, Director
National Institutes of Health
9000 Rockville Pike
Bethesda, MD 20892
Dr Anthony Fauci, Director
NIAID Office of Communications and Government Relations
5601 Fishers Lane, MSC 9806
Bethesda, MD 20892-9806
Margaret A. Hamburg, Commissioner
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993